Ladinin

Ciprofloxacin, the active ingredient in Ladinin, is a fluoroquinolone presented as an intravenous solution for injection use. It treats a broad range of serious bacterial infections in hospitalized patients, including sepsis, intra‑abdominal infections, and complicated urinary tract infections. It is indicated for severe infections caused by susceptible Gram‑negative and Gram‑positive organisms and is administered under medical supervision.

GNH USA supplies Ladinin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides reliable cold‑chain logistics for the IV product.

Ciprofloxacin is employed to treat infections caused by susceptible bacteria across several organ systems. - Severe urinary tract infections: eradicates causative Gram‑negative pathogens and resolves pyelonephritis. - Hospital‑acquired pneumonia: provides coverage against typical and atypical respiratory pathogens. - Intra‑abdominal infections: targets mixed aerobic and anaerobic bacteria in complicated cases. - Skin and soft‑tissue infections: treats cellulitis and wound infections caused by susceptible organisms. - Febrile neutropenia: offers broad‑spectrum antibacterial protection in immunocompromised patients.

Ciprofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Rash - Dizziness

Serious or Rare Side Effects: - Tendon rupture or inflammation - Clostridioides difficile‑associated colitis - QT interval prolongation and cardiac arrhythmias - Severe allergic reactions such as anaphylaxis

Ciprofloxacin requires careful use in specific patient populations and clinical situations. - Renal function: adjust dose in patients with impaired renal clearance. - Central nervous system: monitor for seizures, especially in patients with pre‑existing CNS disorders. - Tendon health: avoid use in individuals with a history of tendon disorders or who are on corticosteroids. - Cardiac risk: caution in patients with known QT prolongation or electrolyte abnormalities. - Pregnancy and lactation: use only if potential benefits justify the risk to the fetus or infant. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Ciprofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: markedly reduce ciprofloxacin absorption. - Warfarin: may potentiate anticoagulant effect, increasing INR. - Theophylline: ciprofloxacin can raise theophylline plasma levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use raises risk of tendon rupture. - Cyclosporine: may increase ciprofloxacin concentrations, requiring monitoring. - Diabetes medications: potential alteration of glucose control, necessitating observation.